Samreen Ahmed
Overview
Explore the profile of Samreen Ahmed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
990
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Planchard D, Janne P, Cheng Y, Yang J, Yanagitani N, Kim S, et al.
Future Oncol
. 2025 Feb;
:1-13.
PMID: 39995095
No abstract available.
2.
Moliner L, Zellweger N, Schmid S, Bertschinger M, Waibel C, Cerciello F, et al.
JTO Clin Res Rep
. 2025 Jan;
6(1):100744.
PMID: 39802819
Introduction: SCLC is characterized by aggressiveness and limited treatment options, especially in extensive-stage SCLC (ES-SCLC). Immunotherapy added to the platinum-etoposide combination has recently become standard in this setting. This retrospective...
3.
Lee S, Hewish M, Ahmed S, Papadatos-Pastos D, Karapanagiotou E, Blackhall F, et al.
Eur J Cancer
. 2024 Dec;
215:115162.
PMID: 39693892
Background: Most patients with small-cell lung cancer (SCLC) present with extensive-stage (ES) disease and have a poor prognosis despite achieving high initial response rates to platinum-based doublet chemotherapy. This study...
4.
Wilson T, Ahmed S, Winningham A, Glover T
Nat Commun
. 2024 Nov;
15(1):9582.
PMID: 39505880
Genomic structural variants (SVs) greatly impact human health, but much is unknown about the mechanisms that generate the largest class of nonrecurrent alterations. Common fragile sites (CFSs) are unstable loci...
5.
Ahmed S, Ahmed S, Gullabzada M, Gullabzada U, Jobanputra K
Cureus
. 2024 Oct;
16(9):e69153.
PMID: 39398676
Uterine fibroids (UFs), or leiomyomas, are common benign tumors affecting a significant proportion of women by the age of 50 years. While typically non-cancerous, UFs can severely impact the quality...
6.
Shaw J, Page K, Wren E, de Bruin E, Kalashnikova E, Hastings R, et al.
JCO Precis Oncol
. 2024 May;
8:e2300456.
PMID: 38691816
Purpose: Here, we report the sensitivity of a personalized, tumor-informed circulating tumor DNA (ctDNA) assay (Signatera) for detection of molecular relapse during long-term follow-up of patients with breast cancer. Methods:...
7.
Steeghs N, Gomez-Roca C, Rohrberg K, Mau-Sorensen M, Robbrecht D, Tabernero J, et al.
Clin Cancer Res
. 2024 Apr;
30(13):2693-2701.
PMID: 38630781
Purpose: Simlukafusp alfa [fibroblast activation protein α-targeted IL2 variant (FAP-IL2v)], a tumor-targeted immunocytokine, comprising an IL2 variant moiety with abolished CD25 binding fused to human IgG1, is directed against fibroblast...
8.
Planchard D, Janne P, Cheng Y, Yang J, Yanagitani N, Kim S, et al.
N Engl J Med
. 2023 Nov;
389(21):1935-1948.
PMID: 37937763
Background: Osimertinib is a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) that is selective for EGFR-TKI-sensitizing and T790M resistance mutations. Evidence suggests that the addition of chemotherapy may extend...
9.
Wilson T, Ahmed S, Higgins J, Salk J, Glover T
NAR Genom Bioinform
. 2023 May;
5(2):lqad042.
PMID: 37181851
Error-corrected sequencing of genomic targets enriched by probe-based capture has become a standard approach for detecting single-nucleotide variants (SNVs) and small insertion/deletions (indels) present at very low variant allele frequencies....
10.
Ready N, Audigier-Valette C, Goldman J, Felip E, Ciuleanu T, Campelo M, et al.
J Immunother Cancer
. 2023 Feb;
11(2).
PMID: 36725084
Background: CheckMate 817, a phase 3B study, evaluated flat-dose nivolumab plus weight-based ipilimumab in patients with metastatic non-small cell lung cancer (NSCLC). Here, in this research, we report on first-line...